Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
7 Results Found
AHA Urges HRSA to Take Immediate Enforcement Action to Block J&J’s Illegal Imposition of 340B Rebate Model
AHA letter regarding the Health Resources and Services Administration’s response to Johnson & Johnson’s (J&J) most recent attempt to undermine the 340B Drug Pricing Program.
AHA, FAH Request Comment Period Extension for Proposed Mandatory Bundled Payment Model
The AHA and FAH comments on the Transforming Episode Accountability Model (TEAM) proposals in the Centers for Medicare & Medicaid Services’ (CMS) inpatient prospective payment system (PPS) proposed rule for fiscal year (FY) 2025.
AHA Letter to Senator Lankford Expressing Support of Congressional Review Act (CRA) Resolutions
The AHA writes in support of S.J.Res. 91, a joint resolution for congressional disapproval of a rule relating to "Medicare and Medicaid Programs; Minimum Staffing Standards for Long-Term Care Facilities and Medicaid Institutional Payment Transparency Reporting."
AHA Letter to Reps. Fischbach and Pence Expressing Support of Congressional Review Act (CRA) Resolutions
AHA writes in support of H.J.Res. 139, a joint resolution for congressional disapproval of a rule relating to "Medicare and Medicaid Programs; Minimum Staffing Standards for Long-Term Care Facilities and Medicaid Institutional Payment Transparency Reporting."
Comments on CMS’ Proposed Rule on Fraudulent Billing Activity within the Medicare Shared Savings Program
AHA's comments on CMS' proposed rule to mitigate the impact of significant, anomalous and highly suspect (SAHS) billing activity within the Medicare Shared Savings Program (MSSP) in calendar year (CY) 2023.
AHA Comments on CMS Medicare Advantage, Part D Proposed Rule for Contract Year 2026
January 27, 2025Jeff WuActing AdministratorCenters for Medicare & Medicaid Services7500 Security BlvdBaltimore, MD 21244
AHA Comments on 340B Drug Pricing Program, IRF Payments, Physician Fee Schedule and Telehealth
AHA comments on MedPAC topics to be considered in the new cycle: the 340B Drug Pricing Program, inpatient rehabilitation facility (IRF) payments, the physician fee schedule (PFS) and telehealth.